US8183344B2
(en)
*
|
1996-04-24 |
2012-05-22 |
University Of Michigan |
Inactivation resistant factor VIII
|
US6479256B1
(en)
|
1998-03-04 |
2002-11-12 |
Icos Corporation |
Lectomedin materials and methods
|
KR20000046969A
(ko)
*
|
1998-12-31 |
2000-07-25 |
이선경 |
이종 유전자 유래의 유전자 발현 조절요소를 포함하는 강력한전사 활성을 가진 진핵세포 발현벡더
|
KR20030040536A
(ko)
*
|
2000-10-12 |
2003-05-22 |
이코스 코포레이션 |
알로스테릭 조절 부위를 함유하는 α/β 단백질의 리간드결합 활성/효소 활성을 조절하는 물질 및 방법
|
WO2002050264A2
(en)
*
|
2000-12-18 |
2002-06-27 |
Wyeth |
Promoters and recombinant expression constructs
|
DE60236332D1
(de)
*
|
2001-07-04 |
2010-06-17 |
Chromagenics Bv |
DNS-Sequenzen mit anti-repressor Aktivität
|
CA2722998C
(en)
*
|
2002-06-14 |
2014-12-02 |
Chromagenics B.V. |
A method for simultaneous production of multiple proteins; vectors and cells for use therein
|
AU2003243059A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Chromagenics B.V. |
Use of repression blocking sequences in methods for enhancing gene expression
|
ATE524559T1
(de)
*
|
2002-12-18 |
2011-09-15 |
Chromagenics Bv |
Methode zur verbesserung der proteinproduktion
|
EP1572994B1
(en)
*
|
2002-12-20 |
2007-02-21 |
Chromagenics B.V. |
Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
|
JP2007506433A
(ja)
|
2003-09-23 |
2007-03-22 |
ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
ビタミンkエポキシド還元酵素遺伝子内の一塩基多型とワルファリン用量とを相関させるための方法および組成物
|
US8039230B2
(en)
*
|
2004-11-08 |
2011-10-18 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
ES2384391T3
(es)
|
2004-11-08 |
2012-07-04 |
Chromagenics B.V. |
Selección de células hospedantes que expresan proteína a altos niveles
|
AU2005300503B2
(en)
*
|
2004-11-08 |
2010-12-16 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
US8999667B2
(en)
*
|
2004-11-08 |
2015-04-07 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
US20060195935A1
(en)
|
2004-11-08 |
2006-08-31 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
WO2006063292A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Icos Corporation |
Recombinant method for making multimeric proteins
|
JP2008532544A
(ja)
*
|
2005-03-15 |
2008-08-21 |
ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
活性ビタミンk依存性タンパク質を生産するための方法及び組成物
|
US8343928B2
(en)
|
2005-07-07 |
2013-01-01 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus
|
WO2007008848A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
AU2006303440B2
(en)
|
2005-10-21 |
2011-09-08 |
F. Hoffmann-La Roche Ag |
Method for the recombinant expression of a polypeptide
|
CN101341252B
(zh)
|
2005-10-28 |
2011-08-17 |
弗·哈夫曼-拉罗切有限公司 |
啮齿动物细胞中的蛋白质表达
|
EP2385125A3
(en)
*
|
2005-12-21 |
2012-04-11 |
Inspiration Biopharmaceuticals, Inc. |
Method of producing biologically active vitamin K dependent proteins by recombinant methods
|
WO2007081336A1
(en)
*
|
2006-01-13 |
2007-07-19 |
Five Prime Therapeutics, Inc. |
Mammalian vectors for high-level expression of recombinant proteins
|
EP2208792B1
(en)
|
2006-05-17 |
2015-05-06 |
Hoffmann-La Roche AG |
Polypeptide producing cells
|
US20090203077A1
(en)
*
|
2006-06-30 |
2009-08-13 |
The Regents Of The University Of Michigan |
Method of producing factor viii proteins by recombinant methods
|
US20080070251A1
(en)
*
|
2006-06-30 |
2008-03-20 |
Kaufman Randal J |
Method of Producing Factor VIII Proteins by Recombinant Methods
|
US20090143288A1
(en)
*
|
2007-03-13 |
2009-06-04 |
Roche Palo Alto Llc |
Peptide-complement conjugates
|
EP1975228A1
(en)
|
2007-03-28 |
2008-10-01 |
Fachhochschule Mannheim |
Polynucleotides for enhancing expression of a polynucleotide of interest
|
CA2683423C
(en)
|
2007-04-26 |
2020-10-27 |
Inspiration Biopharmaceuticals, Inc. |
Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same
|
JP5512514B2
(ja)
*
|
2007-06-29 |
2014-06-04 |
エフ.ホフマン−ラ ロシュ アーゲー |
改善された免疫グロブリンの産生をもたらす重鎖変異体
|
ES2695999T3
(es)
|
2007-10-12 |
2019-01-11 |
Hoffmann La Roche |
Expresión de proteínas a partir de múltiples ácidos nucleicos
|
JP5580205B2
(ja)
|
2007-11-19 |
2014-08-27 |
セレラ コーポレーション |
肺癌マーカーとその使用
|
MY158228A
(en)
|
2008-04-24 |
2016-09-15 |
Cantab Biopharmaceuticals Patents Ltd |
Factor ix conjugates with extended half-lives
|
PL2282773T3
(pl)
|
2008-05-02 |
2014-08-29 |
Seattle Genetics Inc |
Sposoby i kompozycje do wytwarzania przeciwciał i pochodnych przeciwciał o obniżonej fukozylacji rdzeniowej
|
SI2462237T1
(sl)
|
2009-08-06 |
2016-04-29 |
Cmc Icos Biologics, Inc. |
Postopki za izboljšanje ekspresije rekombinantnega proteina
|
US8822214B2
(en)
|
2009-09-15 |
2014-09-02 |
Medimmune Limited |
Cells for transient expression and uses thereof
|
JP5851410B2
(ja)
|
2009-10-30 |
2016-02-03 |
シーエヌジェイ ホールディングス、インク. |
組換えビタミンk依存性タンパク質の生成法
|
EP2339009A1
(en)
|
2009-12-22 |
2011-06-29 |
Sandoz Ag |
Cold inducible promoter sequences
|
RS57114B1
(sr)
|
2010-03-31 |
2018-06-29 |
Boehringer Ingelheim Int |
Anti-cd40 antitela
|
UA112062C2
(uk)
|
2010-10-04 |
2016-07-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cd33-зв'язувальний агент
|
CN103282382B
(zh)
|
2010-11-04 |
2017-11-03 |
勃林格殷格翰国际有限公司 |
抗il‑23抗体
|
EP2655607A4
(en)
|
2010-12-21 |
2014-05-14 |
Univ North Carolina |
METHOD AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS
|
EP2753644A1
(en)
|
2011-09-09 |
2014-07-16 |
Universiteit Utrecht Holding B.V. |
Broadly neutralizing vhh against hiv-1
|
PE20141568A1
(es)
|
2011-10-28 |
2014-11-21 |
Neotope Biosciences Ltd |
Anticuerpos humanizados que reconocen la alfa-sinucleina
|
AP2014007571A0
(en)
|
2011-11-16 |
2014-04-30 |
Boehringer Ingelheim Int |
Anti IL-36R antibodies
|
ES2791758T3
(es)
|
2011-12-22 |
2020-11-05 |
Hoffmann La Roche |
Organización de vectores de expresión, procedimientos de generación de células de producción novedosos y su uso para la producción recombinante de polipéptidos
|
MX2014007262A
(es)
|
2011-12-22 |
2014-08-01 |
Hoffmann La Roche |
Sistema de exhibicion de anticuerpos de longitud completa para celulas eucarioticas y su uso.
|
MX355624B
(es)
|
2011-12-22 |
2018-04-25 |
Hoffmann La Roche |
Combinaciones de elementos de vector de expresion, metodos novedosos de generacion de celulas de produccion y su uso para la produccion recombinante de polipeptidos.
|
SG11201404321YA
(en)
|
2012-01-27 |
2014-08-28 |
Neotope Biosciences Ltd |
Humanized antibodies that recognize alpha-synuclein
|
CN108324943B
(zh)
|
2012-02-10 |
2024-03-08 |
思进股份有限公司 |
Cd30+癌症的检测和治疗
|
US20130230901A1
(en)
*
|
2012-02-14 |
2013-09-05 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|
KR102124758B1
(ko)
|
2012-05-03 |
2020-06-19 |
베링거 인겔하임 인터내셔날 게엠베하 |
항-il-23p19 항체
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
AU2013348029A1
(en)
|
2012-11-20 |
2015-07-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for modified factor IX proteins
|
CN105209625B
(zh)
|
2013-03-12 |
2019-03-29 |
Cmc依科斯生技制品公司 |
使用杂合chef1启动子的改善重组蛋白表达
|
CU24446B1
(es)
|
2013-03-13 |
2019-10-04 |
Prothena Biosciences Ltd |
Un anticuerpo monoclonal humanizado que se une a tau
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
RU2535871C1
(ru)
*
|
2013-07-10 |
2014-12-20 |
Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") |
Плазмида для экспрессии в клетке китайского хомячка, клетка китайского хомячка - продуцент белка с Gla-доменом и способ получения белка с Gla-доменом
|
US9850302B2
(en)
|
2013-07-12 |
2017-12-26 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
WO2015004633A1
(en)
|
2013-07-12 |
2015-01-15 |
Neotope Biosciences Limited |
Antibodies that recognize islet-amyloid polypeptide (iapp)
|
EP3071974A2
(en)
|
2013-11-19 |
2016-09-28 |
Prothena Biosciences Limited |
Monitoring immunotherapy of lewy body disease from constipation symptoms
|
KR20160113715A
(ko)
|
2014-01-31 |
2016-09-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
신규한 항-baff 항체
|
KR20160131082A
(ko)
|
2014-03-12 |
2016-11-15 |
프로테나 바이오사이언시즈 리미티드 |
Lg1-3에 특이적인 항-라미닌4 항체
|
WO2015136472A1
(en)
|
2014-03-12 |
2015-09-17 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg4-5
|
KR20160127825A
(ko)
|
2014-03-12 |
2016-11-04 |
프로테나 바이오사이언시즈 리미티드 |
항-mcam 항체 및 관련된 사용 방법
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
WO2015155694A1
(en)
|
2014-04-08 |
2015-10-15 |
Prothena Biosciences Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
JP2017524359A
(ja)
|
2014-07-24 |
2017-08-31 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Il−23a関連疾患の処置に有用なバイオマーカー
|
TWI781507B
(zh)
|
2015-01-28 |
2022-10-21 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI786505B
(zh)
|
2015-01-28 |
2022-12-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI711631B
(zh)
|
2015-01-28 |
2020-12-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
KR20230110654A
(ko)
|
2015-02-06 |
2023-07-24 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
최적화된 인간 응고 인자 viii 유전자 발현 카세트및 그의 용도
|
EP3283109A1
(en)
|
2015-04-14 |
2018-02-21 |
Boehringer Ingelheim International GmbH |
Methods of treating diseases
|
EP3294335B1
(en)
|
2015-05-12 |
2023-07-05 |
Syntimmune Inc. |
Humanized affinity matured anti-fcrn antibodies
|
JP2018530540A
(ja)
|
2015-09-16 |
2018-10-18 |
プロセナ バイオサイエンシーズ リミテッド |
巨細胞動脈炎、リウマチ性多発筋痛症又は高安動脈炎の処置又は予防のための抗mcam抗体の使用
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
TWI733695B
(zh)
|
2015-09-18 |
2021-07-21 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
US11560418B2
(en)
|
2015-10-20 |
2023-01-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for modified factor IX fusion proteins
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
EP3744733A3
(en)
|
2016-04-15 |
2021-02-24 |
Boehringer Ingelheim International GmbH |
Methods of treating inflammatory diseases
|
AU2017257680A1
(en)
|
2016-04-25 |
2018-12-06 |
Syntimmune, Inc. |
Humanized affinity matured anti-FcRn antibodies
|
EP3452508A1
(en)
|
2016-05-02 |
2019-03-13 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
CN109415432B
(zh)
|
2016-05-02 |
2022-07-08 |
普罗塞纳生物科学有限公司 |
Tau免疫疗法
|
CA3022765A1
(en)
|
2016-05-02 |
2017-11-09 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
JP7016470B2
(ja)
|
2016-07-02 |
2022-02-07 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
WO2018007924A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
WO2018007922A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
EP3472198B1
(en)
|
2016-09-29 |
2020-03-04 |
H. Hoffnabb-La Roche Ag |
Improved method for selecting polypeptide producing cells
|
EP3677597A1
(en)
|
2016-10-14 |
2020-07-08 |
Boehringer Ingelheim International GmbH |
Methods of treating diseases
|
EP3601350A1
(en)
|
2017-03-27 |
2020-02-05 |
Boehringer Ingelheim International GmbH |
Anti il-36r antibodies combination therapy
|
KR20200030029A
(ko)
|
2017-05-02 |
2020-03-19 |
프로테나 바이오사이언시즈 리미티드 |
타우 인식 항체
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
AU2017434556A1
(en)
|
2017-09-28 |
2020-04-09 |
F. Hoffmann-La Roche Ag |
Dosing regimes for treatment of synucleinopathies
|
US20210062217A1
(en)
|
2018-01-10 |
2021-03-04 |
Agc Biologics, Inc. |
Bidirectional chef1 vectors
|
US20210032316A1
(en)
|
2018-02-05 |
2021-02-04 |
Stichting Vu |
Inverse Agonistic Anti-US28 Antibodies
|
WO2019156566A1
(en)
|
2018-02-12 |
2019-08-15 |
Umc Utrecht Holding B.V. |
Bispecific molecules comprising gamma-delta tcr and t-cell or nk cell binding domain
|
WO2019226050A2
(en)
|
2018-05-24 |
2019-11-28 |
Wageningen Universiteit |
Novel viral anti-infective reagents
|
WO2019235923A1
(en)
|
2018-06-04 |
2019-12-12 |
Erasmus University Medical Center Rotterdam |
Role for low density lipoprotein receptor-related protein 10 in progressive brain diseases
|
CA3101469A1
(en)
|
2018-06-29 |
2020-01-02 |
Boehringer Ingelheim International Gmbh |
Anti-cd40 antibodies for use in treating autoimmune disease
|
CN110904127A
(zh)
|
2018-09-18 |
2020-03-24 |
瓦赫宁恩研究基金会 |
非洲猪瘟病毒疫苗
|
WO2020080941A1
(en)
|
2018-10-16 |
2020-04-23 |
Umc Utrecht Holding B.V. |
Anti- low-density lipoprotein receptor-related protein 5/6 antibodies
|
KR20210094610A
(ko)
|
2018-11-26 |
2021-07-29 |
포티 세븐, 인코포레이티드 |
c-Kit에 대한 인간화 항체
|
WO2020130838A2
(en)
|
2018-12-21 |
2020-06-25 |
Qvq Holding B.V. |
Antibodies for preventing or treating candidiasis
|
PE20212324A1
(es)
|
2019-03-03 |
2021-12-14 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
TW202100141A
(zh)
|
2019-03-08 |
2021-01-01 |
德商百靈佳殷格翰國際股份有限公司 |
抗il-36r抗體調配物
|
JP2022529139A
(ja)
|
2019-04-02 |
2022-06-17 |
イミュネチューン・ベー・フェー |
免疫刺激組成物及びその使用
|
JP7314310B2
(ja)
|
2019-05-09 |
2023-07-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
眼又は眼疾患を処置するための抗セマフォリン3a抗体及びその使用
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
KR20230015997A
(ko)
|
2020-05-26 |
2023-01-31 |
베링거 인겔하임 인터내셔날 게엠베하 |
항-pd-1 항체
|
EP4288457A2
(en)
|
2021-02-05 |
2023-12-13 |
Boehringer Ingelheim International GmbH |
Anti-il1rap antibodies
|
AU2022420788A1
(en)
|
2021-12-22 |
2024-05-16 |
Boehringer Ingelheim International Gmbh |
Anti-c3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases
|
CN114540352A
(zh)
*
|
2022-02-16 |
2022-05-27 |
艾瑞生命科学技术(常州)有限公司 |
一种多核苷酸、载体元件及表达载体和宿主细胞及应用
|
WO2024096735A1
(en)
|
2022-10-31 |
2024-05-10 |
Stichting Amsterdam UMC |
Single domain anti-cd169 antibodies
|
WO2024101989A1
(en)
|
2022-11-08 |
2024-05-16 |
Stichting Amsterdam UMC |
Activation inducible antigen receptors for adoptive immunotherapy
|